Why Partner

Position Your Company at the Forefront of Gene Editing

With 2025 shaping up to be yet another momenteous year for genome editing therapeutics, connect with the experts actively advancing the next wave of safe and durable therapies at the 6th Genome Editing Therapeutics Summit 

This much-loved forum provides you with an unmatched platform to showcase your company’s services, expertise, solutions and brand to the growing number of biopharma, continuing to incorporate gene editing into their development.  

From our research this year, we know that senior leaders are eager to partner with organizations with reliable solutions and robust capabilities to support: 

6

CDMOs

CDMOs

CRISPR Construct Providers & Reagents

2

Vector Providers  

3

CROs  

5
CDMOs (2)
1
4

Animal Model Providers

CRISPR-Engineered Cell Lines 

Genome Sequencing 

Genomic Analysis 

Reach out today to discuss how we can support you in establishing strong relationships with this unique group through one of our trusted partnership positions. 

Proud to Partner With

6th Genome Editing Therapeutics Summit - Partner 2025
6th Genome Editing Therapeutics Summit - Partner 2025
6th Genome Editing Therapeutics Summit - Partner 2025
6th Genome Editing Therapeutics Summit - Partner 2025

“The Genome Editing Therapeutics Summit was outstanding. There was opportunity to network with all participants and because of the smaller size of the conference, we were able to have free flowing conversations”

Radhika Ganeshan, Product Manager, Aldevron, 2025 Sponsor

6th Genome Editing Therapeutics Summit - Audience Breakdown 1
6th Genome Editing Therapeutics Summit - Audience Breakdowns

Meet with Leading Genome Editing Experts

6th Genome Editing Therapeutics Summit - Companies in the Room 3

Become a Partner

Megan Poole
Partnership Director
Hanson Wade

6th Genome Editing Therapeutics Summit - Partnership Opportunities 2025